Who invested in Medopad?
Medopad's investors include Bayer, Intel, Vodafone and China’s NWS Holdings. Bayer led its latest round.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$54Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
Medopad filed 11 raises, $163M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Medopad's investors include Bayer, Intel, Vodafone and China’s NWS Holdings. Bayer led its latest round.
Medopad has raised $54M across 5 rounds since 2012.
Medopad's most recent round was a Series B of $25M in Nov 2019, led by Bayer.
Medopad's largest round on record is $26M (Series A), in Feb 2018.
Medopad's first round on record, in Mar 2014, was backed by Intel and Vodafone.
Medopad's latest named round is a Series B, in Nov 2019.
Medopad is based in the United Kingdom.
Bayer led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.